MUSCELLA, Antonella
 Distribuzione geografica
Continente #
EU - Europa 10.846
NA - Nord America 10.003
AS - Asia 7.741
SA - Sud America 1.320
Continente sconosciuto - Info sul continente non disponibili 391
AF - Africa 200
OC - Oceania 11
AN - Antartide 1
Totale 30.513
Nazione #
US - Stati Uniti d'America 9.581
SG - Singapore 3.457
IT - Italia 3.440
IE - Irlanda 2.533
RU - Federazione Russa 2.105
CN - Cina 1.415
HK - Hong Kong 1.120
BR - Brasile 1.081
VN - Vietnam 671
SE - Svezia 667
UA - Ucraina 529
DE - Germania 449
IN - India 343
FR - Francia 267
FI - Finlandia 260
GB - Regno Unito 233
CA - Canada 223
KR - Corea 148
BD - Bangladesh 133
MX - Messico 96
AR - Argentina 92
JP - Giappone 88
ZA - Sudafrica 70
PL - Polonia 63
IQ - Iraq 61
PK - Pakistan 52
EC - Ecuador 45
ES - Italia 44
NL - Olanda 43
SN - Senegal 43
ID - Indonesia 41
TR - Turchia 41
BE - Belgio 39
LT - Lituania 33
CZ - Repubblica Ceca 30
IR - Iran 29
AT - Austria 22
VE - Venezuela 21
AE - Emirati Arabi Uniti 20
CO - Colombia 20
JM - Giamaica 20
TN - Tunisia 18
CL - Cile 17
CR - Costa Rica 16
MA - Marocco 16
UZ - Uzbekistan 16
EG - Egitto 14
PY - Paraguay 14
MY - Malesia 13
PE - Perù 13
SA - Arabia Saudita 12
SV - El Salvador 12
HN - Honduras 11
IL - Israele 11
NP - Nepal 11
BG - Bulgaria 10
GT - Guatemala 10
RO - Romania 10
CH - Svizzera 9
DZ - Algeria 9
HU - Ungheria 9
AU - Australia 8
EE - Estonia 8
KE - Kenya 8
UY - Uruguay 8
BO - Bolivia 7
ET - Etiopia 7
JO - Giordania 7
CW - ???statistics.table.value.countryCode.CW??? 6
NI - Nicaragua 6
PR - Porto Rico 6
AL - Albania 5
AZ - Azerbaigian 5
EU - Europa 5
LB - Libano 5
PH - Filippine 5
PS - Palestinian Territory 5
PT - Portogallo 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BA - Bosnia-Erzegovina 4
GR - Grecia 4
MD - Moldavia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
BZ - Belize 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
KZ - Kazakistan 3
SC - Seychelles 3
SI - Slovenia 3
AO - Angola 2
BW - Botswana 2
CG - Congo 2
CI - Costa d'Avorio 2
Totale 30.096
Città #
Dublin 2.527
Lecce 2.466
Singapore 1.241
Ashburn 1.122
San Jose 1.079
Hong Kong 1.044
Council Bluffs 870
Moscow 652
Chandler 511
Dallas 496
Beijing 370
New York 314
Jacksonville 289
Santa Clara 253
Ho Chi Minh City 240
Los Angeles 212
Wayanad 189
Princeton 172
Lauterbourg 168
Milan 166
Hanoi 164
Munich 157
Seoul 142
São Paulo 127
Des Moines 99
Frankfurt am Main 99
Orem 87
Tokyo 82
Phoenix 81
Brooklyn 79
Helsinki 79
Bari 68
Montreal 68
Atlanta 64
Rome 59
Wilmington 58
Chennai 57
Chicago 57
Denver 56
London 55
Seattle 55
West Jordan 55
Ogden 54
Ann Arbor 50
Central District 50
Warsaw 50
Mexico City 47
Lequile 44
Dakar 43
Johannesburg 42
Stockholm 42
Toronto 42
Poplar 41
Rio de Janeiro 41
Houston 39
Boston 38
Miano 38
Brussels 36
Da Nang 35
Naples 34
Seelze 34
Detroit 32
Bakersfield 31
Haiphong 30
Miami 28
Copertino 27
Kent 27
Manchester 27
San Francisco 27
San Pietro Vernotico 26
Baghdad 25
Columbus 25
Falkenstein 25
Turku 25
The Dalles 24
Jinan 23
Nuremberg 23
Ankara 22
Brasília 22
Guangzhou 22
Lappeenranta 22
Boardman 21
Brno 21
Falls Church 21
Amsterdam 19
Mumbai 19
North Bergen 19
St Louis 19
Augusta 18
San Mateo 18
Bologna 17
Bremen 17
Tianjin 17
Kingston 16
Lahore 16
Querétaro 16
Zhengzhou 16
Belo Horizonte 15
Curitiba 15
Shanghai 15
Totale 17.877
Nome #
Evaluation of the Antitumor Effects of Platinum-Based [Pt(η1-C2H4-OR)(DMSO)(phen)]+ (R = Me, Et) Cationic Organometallic Complexes on Chemoresistant Pancreatic Cancer Cell Lines 267
Exchequer motor game enhances geometric thinking and mood in first grade children 267
A monoclonal antibody to mammalian Angiotensin II AT1 receptor recognises one of the Angiotensin II receptor isoforms expressed by the eels. 262
INJURY PREVENTION IN YOUNG SOCCER PLAYERS: RESULTS OF A PILOT STUDY 261
[Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway 257
ADP sensitizes ZL55 cells to the activity of cisplatin 254
[Pt(O,O'-acac)(γ-acac)(DMS)] induces autophagy and apoptosis in Skov-3 ovarian carcinoma cells 254
Inhibition of ZL55 cell proliferation by ADP via PKC-dependent signalling pathway 251
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits malignant pleural mesothelioma cells in vitro and in vivo 249
A new platinum(II) complex with high cytotoxicity in human endometrial cancer HeLa cells. 246
Referees' physical performance over a soccer season 245
[Pt(O,O'-acac)(γ-acac)(DMS)] Induces Autophagy in Caki-1 Renal Cancer Cells 242
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells. 240
A new platinum (II) complex exerts higher cytotoxicity in tumoral than in normal human breast cells in primary culture. 237
Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma 236
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells 234
[Pt(O,O'-acac)(gamma-acac)(DMS)] alters the expression of genes for cell cycle regulation and invasive function 233
ADP sensitizes ZL55 cells to the activity of anticancer cisplatin 233
[Pt(O,O’-acac)(γ-acac)(DMS)] affects the intracellular Ca2+ homeostasis in MCF-7 breast cancer cells 232
A new platinum(II) complex with high cytotoxicity in normal and tumoural thyroid cell lines 230
[Pt(O,O’-acac)(γ-acac)(DMS)] exerts high and fast cytotoxicity in breast cancer cells in primary culture 229
Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells 229
Antitumor and Antiangiogenic Activities of [Pt(O,O' acac)(γ-acac)(DMS)] in human renal cell carcinoma 224
[Pt(O,O’-acac)(γ-acac)(DMS)]: in vivo Studies of a Promising Anticancer Drug in Cancer Therapy 224
In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma 222
[Pt(O,O’-acac)(γ-acac)(DMS)]: a comparative study with cisplatin in vivo. 221
1H-NMR metabolomic study of SKOV-3 cells, response to the [Pt(O,O′-acac)(γ-acac)(DMS)] treatment 220
Antitumor and antimigration effects of a new Pt compound on neuroblastoma cells 219
[Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway. 219
PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin 218
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects 216
Activation of P2Y2 purinoceptor inhibits the activity of the Na+/K+ATPase in HeLa cells 212
Cytotoxicity of new organometallic Pt(II)-complexes containing 1,10-phenantroline 211
Antitumor activity of [Pt(O,O’-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer 208
Response of cisplatin resistant SkOV-3 cells to [PT(O,O'-Acac)(γ-Acac)(DMS)] Treatment revealed by a metabolomic 1H-NMR study 207
[Pt(O,O’-acac)(γ-acac)(DMS)] inhibits adhesion and migration of breast cancer cells 206
The effects of exercise training on lipid metabolism and coronary heart disease 206
Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells 205
Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture. 204
The effects of training on hormonal concentrations in young soccer players 202
Cisplatin-analogous β-diketonate Pt(II) organometallic species: reactivity and cytotoxicity 198
Activation of P2Y2 receptor induces C-Fos protein through a pathway Involving Mitogen-Activated Protein Kinase and phosphoinositide 3-kinases in HeLa cells. 198
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits migration of tumor human breast cells in primary cultures 198
A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells 196
Antitumor Effects Induced by the Promising Drug [Pt(O,O′-acac)(γ-acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): a 1H NMR Metabolomic Study 196
Angiotensin II stimulates the Na+/H+ exchanger in human umbilical vein endothelial cells via AT1 receptor 194
Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells 193
Differential functions of PKC-delta and PKC-zeta in cisplatin response of normal and transformed thyroid cells. 192
[Pt(O,O’-acac)(γ-acac)(DMS)] induces apoptosis in human breast cancer cells in primary culture 191
Is mitochondrial DNA profiling predictive for athletic performance? 189
Transbulbar B-Mode Sonography in Multiple Sclerosis: Clinical and Biological Relevance 187
Cisplatin activates the PKC/ERK1/2 intracellular transduction pathways in rat thyroid PC Cl3 cells 186
Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment 185
Angiotensin II stimulation of the basolateral located Na/H antiporter in eel (Anguilla anguilla) enterocytes 183
Cytotoxicity of [Pt(O,O’-acac)(γ-acac)(DMS)] in normal and cancerous human breast cells in primary culture 181
Dopamine and antioxidant grape seed extract loaded chitosan nanoparticles: A preliminary in vitro characterization. 180
Bradykinin stimulates prostaglandin E2 release in human skeletal muscular fibroblasts 179
NMR-based metabolomic analyses of cisplatin resistant SKOV-3 cell line response to [Pt (O,O′-acac)(γ-acac)(DMS)], Ptac2S, treatment: comparison to cisplatin 178
Immunolocalization of the AT-1R Ang II Receptor in Human Kidney Cancer 177
The Angiosuppressive Effects of [Pt(O,O′-acac)(γ-acac)(DMS)] 175
Different regulation of matrix metalloproteinase-2 in cisplatin response of normal and transformed thyroid cells 173
Protein kinase C-delta mediates cisplatin-induced apoptosis of ZL55 mesothelioma cells 173
Synthesis and comparative evaluation of the cytotoxic activity of cationic organometallic complexes of the type [Pt(η1-CH2-CH2-OR)(DMSO)(phen)]+ (R = Me, Et, Pr, Bu) 172
Multiple isoforms of the oestrogen receptor in endometrial cancer 172
Immunolocalisation of angiotensin II receptors in icefish (Chionodraco hamatus) tissues. 171
Adenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells 171
A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells 170
Synthesis and characterization of new water-soluble organometallic complexes of the type [PtL(h1-C2H4OMe)(N^N)] (L = NH3, DMSO; N^N = dinitrogen ligand) with potential antitumor activity 170
NEW B-DIKETONATE PT(II) ORGANOMETALLIC SPECIES EXHIBITING HIGHER CYTOTOXIC ACTIVITY ON CANCER CELLS THAN CISPLATIN. 169
AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma 168
Cytotoxic Activity of New β-Diketonate Platinum(II) Complexes on Cancer Cells 168
PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells 168
CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture 167
A novel monoclonal antibody to a plasmamembrane-located breast cancer antigen Interferes with the proliferation rate of cancerous cells in vitro 166
Angiotensin II AT1 Receptor Stimulates Na+/K+ATPase Activity Through a Pathway Involving PKC-z in Rat Thyroid Cells. 166
Mitochondria-mediated apoptosis by a new Pt(II) compound, [Pt(O,O’-acac)(g-acac) (DMS)], in human breast cancer cells 165
Purinergic receptors in a pleural mesotelioma cell line. 165
Effect of tumour size on the association between pS2 and cathepsin D in primary breast cancer 164
Involvement of Protein Kinase Cdelta and -epsilon in cisplatin-induced apoptosis in thyroid cells. 162
Angiotensin II modulates the activity of Na+/K+ATPase in cultured rat astrocytes via the AT1 receptor and protein kinase C-delta activation 160
Synthesis, characterization and cytotoxic activity of novel Pt(II) complexes with acetylacetonate and amines 160
Monitoring Psychometric States of Recovery to Improve Performance in Soccer Players: A Brief Review 157
Novel Pt (II) Complexes With Anticancer Activity Against Pancreatic Ductal Adenocarcinoma Cells 157
Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. 157
EGFR MEDIATES THE CYTOTOXICITY OF CISPLATIN IN THE DIFFERENTIATED RAT THYROID PC CL3 CELL LINE THROUGH THE ACTIVATION OF MAPK/P38 156
Increase of [Ca2+]i via activation of ATP receptors in PC-Cl3 rat thyroid cell line 156
CCL20 induces migration and proliferation on breast epithelial cells 154
Transforming growth factor-β1 induces matrix metalloproteinase and cell migration in Schwann cells. 154
Different Cytotoxic Effects of Cisplatin on Pancreatic Ductal Adenocarcinoma Cell Lines 153
PKC-epsilon-dependent cytosol-to-membrane translocation of pendrin in rat thyroid PC Cl3 cells. 153
Differential activation of ERK1/2 in human breast cancer MCF-7 cells treated with cisplatin or [Pt(O,O’-acac)(γ-acac)(DMS)] 153
In vivo study on xenograft model: [Pt(O,O’-acac)(γ-acac)(DMS)] versus cisplatin 152
ERK activation in cisplatin response in thyroid cell lines 151
Molecular Studies on Cisplatin Analogues 151
Effects of extracellular nucleotides in the thyroid: P2Y(2) receptor-mediated ERK1/2 activation and c-Fos induction in PC Cl3 cells 150
Cytotoxic activity in vitro of cisplatin and its analogous [Pt(acac)Cl(DMSO)]. 150
The effects of training on hormonal concentrations and physical performance of football referees 150
Efficacy of school-based intervention programs in reducing overweight: A randomized trial 149
Angiotensin II receptors in the gill of sea water- and freshwater-adapted eel 149
Involvement of Protein Kinase C-delta and -epsylon in cisplatin-induced apoptosis in thyroid cells 149
Totale 19.409
Categoria #
all - tutte 138.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022730 0 0 0 78 109 12 22 49 21 64 118 257
2022/20234.325 192 334 173 132 156 268 29 189 2.681 14 98 59
2023/20241.581 132 91 107 92 133 158 22 58 221 307 173 87
2024/20255.122 98 29 109 80 342 558 180 249 1.679 538 477 783
2025/202611.849 1.086 1.413 1.024 1.550 1.243 570 1.365 534 1.615 811 438 200
2026/20273.107 306 769 561 1.471 0 0 0 0 0 0 0 0
Totale 30.513